These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 24354679)

  • 21. Krüppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by inhibition of NOTCH signaling.
    Filarsky K; Garding A; Becker N; Wolf C; Zucknick M; Claus R; Weichenhan D; Plass C; Döhner H; Stilgenbauer S; Lichter P; Mertens D
    Haematologica; 2016 Jun; 101(6):e249-53. PubMed ID: 27081174
    [No Abstract]   [Full Text] [Related]  

  • 22. Immediate causes of death in Burkitt lymphoma patients in Ibadan.
    Durodola JI
    J Natl Med Assoc; 1980 Mar; 72(3):209-13. PubMed ID: 7392066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the reprogramming factor KLF4 in blood formation.
    Park CS; Shen Y; Lewis A; Lacorazza HD
    J Leukoc Biol; 2016 May; 99(5):673-85. PubMed ID: 26908828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
    Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
    Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of transcription factor Oct-1 in the regulation of JAK-STAT signaling pathway in cells of Burkitt lymphoma.
    Pankratova EV; Stepchenko AG; Krylova ID; Portseva TN; Georgieva SG
    Dokl Biochem Biophys; 2016 May; 468(1):229-31. PubMed ID: 27417729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomas.
    Kujawski LA; Longo WL; Williams EC; Turman NJ; Brandt N; Mosher DF; Eickhoff JC; Kahl BS
    Cancer Invest; 2007 Mar; 25(2):87-93. PubMed ID: 17453819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt lymphoma.
    Yoon JW; Gallant M; Lamm ML; Iannaccone S; Vieux KF; Proytcheva M; Hyjek E; Iannaccone P; Walterhouse D
    Mol Cancer Res; 2013 Jun; 11(6):604-15. PubMed ID: 23525267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mediastinal Burkitt lymphoma in childhood.
    Pillon M; Aricò M; Mussolin L; Mainardi C; Giraldi E; Garaventa A; Lombardi A; Santoro N; Carraro E; d'Amore ES; Rosolen A;
    Pediatr Blood Cancer; 2014 Nov; 61(11):2127-8. PubMed ID: 25053233
    [No Abstract]   [Full Text] [Related]  

  • 29. Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons.
    Hutchison RE; Finch C; Kepner J; Fuller C; Bowman P; Link M; Schwenn M; Laver J; Desai S; Barrett D; Murphy SB
    Ann Oncol; 2000; 11 Suppl 1():35-8. PubMed ID: 10707776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Backbone
    Conroy BS; Weiss ER; Smith SP; Langelaan DN
    Biomol NMR Assign; 2017 Apr; 11(1):95-98. PubMed ID: 28247282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased level of Oct-1 protein in tumor cells modulates cellular response to anticancer drugs.
    Portseva TN; Pankratova EV; Stepchenko AG; Georgieva SG
    Dokl Biochem Biophys; 2016 Jul; 469(1):269-72. PubMed ID: 27599509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Burkitt lymphoma in children: the Israeli experience.
    Eldar AH; Futerman B; Abrahami G; Attias D; Barak AB; Burstein Y; Dvir R; Gabriel H; Horovitz J; Kapelushnik J; Kaplinsky H; Miskin H; Sthoeger D; Toren A; Vilk-Revel S; Weintraub M; Yaniv I; Linn S; Arush MB
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):428-36. PubMed ID: 19648792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol.
    Pillon M; Mussolin L; Carraro E; Conter V; Aricò M; Vinti L; Garaventa A; Piglione M; Buffardi S; Sala A; Santoro N; Lo Nigro L; Mura R; Tondo A; Casale F; Farruggia P; Pierani P; Cesaro S; d'Amore ES; Basso G
    Br J Haematol; 2016 Nov; 175(3):467-475. PubMed ID: 27392319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival in Burkitt's lymphoma.
    Lancet; 1969 Jul; 2(7613):200. PubMed ID: 4183148
    [No Abstract]   [Full Text] [Related]  

  • 35. Kruppel-like factors in muscle health and disease.
    Prosdocimo DA; Sabeh MK; Jain MK
    Trends Cardiovasc Med; 2015 May; 25(4):278-87. PubMed ID: 25528994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sports or statins for atheroprotection? New insight from Kruppel-like factor 2.
    Thum T; Bauersachs J
    Cardiovasc Res; 2006 Nov; 72(2):193-5. PubMed ID: 17010325
    [No Abstract]   [Full Text] [Related]  

  • 37. The critical role of Krüppel-like factors in kidney disease.
    Mallipattu SK; Estrada CC; He JC
    Am J Physiol Renal Physiol; 2017 Feb; 312(2):F259-F265. PubMed ID: 27852611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastric Burkitt lymphoma is a distinct subtype that has superior outcomes to other types of Burkitt lymphoma/leukemia.
    Park YH; Kim WS; Kang HJ; Na II; Ryoo BY; Yang SH; Lee SS; Uhm JE; Kim K; Jung CW; Park K; Ko YH
    Ann Hematol; 2006 May; 85(5):285-90. PubMed ID: 16518604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemoimmunotherapy as a new standard of care for Burkitt leukaemia/lymphoma.
    Jabbour E; Kantarjian H
    Lancet; 2016 Jun; 387(10036):2360-1. PubMed ID: 27080497
    [No Abstract]   [Full Text] [Related]  

  • 40. Primary Burkitt-like lymphoma presenting as a solitary rectal polyp in a child: case report.
    Zhang X; Beneck D; Bostwick HE; Weisberger J
    Pediatr Dev Pathol; 2003; 6(2):182-6. PubMed ID: 12522693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.